Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy. - Wikidata - awgldk - TriplyDB

Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy.

Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy.

http://www.wikidata.org/entity/Q34588169

about

Genome-wide association study identifies single nucleotide polymorphism in DYRK1A associated with replication of HIV-1 in monocyte-derived macrophages The aftermath of the Merck's HIV vaccine trial How to Define the Latent Reservoir: Tools of the Trade Barriers to a cure for HIV in women Epigenetic control of HIV-1 post integration latency: implications for therapy Redefining the viral reservoirs that prevent HIV-1 eradication Animal models in HIV cure research Plasmacytoid dendritic cells of the gut: relevance to immunity and pathology The immunological synapse: the gateway to the HIV reservoir Recent developments in human immunodeficiency virus-1 latency research Incomplete immune recovery in HIV infection: mechanisms, relevance for clinical care, and possible solutions Anti-α4 antibody treatment blocks virus traffic to the brain and gut early, and stabilizes CNS injury late in infection Comparative Analysis of Immune Activation Markers of CD8(+) T Cells in Lymph Nodes of Different Origins in SIV-Infected Chinese Rhesus Macaques Persistence of viral reservoirs in multiple tissues after antiretroviral therapy suppression in a macaque RT-SHIV model Tissue-specific B-cell dysfunction and generalized memory B-cell loss during acute SIV infection The Dynamics of T and B Cells in Lymph Node during Chronic HIV Infection: TFH and HIV, Unhappy Dance Partners?Using animal models to overcome temporal, spatial and combinatorial challenges in HIV persistence research Reappearance of minority K103N HIV-1 variants after interruption of ART initiated during primary HIV-1 infection Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized Trial Switching virally suppressed, treatment-experienced patients to a raltegravir-containing regimen does not alter levels of HIV-1 DNA Intensification of antiretroviral therapy with a CCR5 antagonist in patients with chronic HIV-1 infection: effect on T cells latently infected Cardiovascular Disease, Statins, and HIV The Role of Caveolin 1 in HIV Infection and Pathogenesis.Combination antiretroviral drugs in PLGA nanoparticle for HIV-1.Modelling imperfect adherence to HIV induction therapy HIV viremia and incidence of non-Hodgkin lymphoma in patients successfully treated with antiretroviral therapy.Immunotoxin complementation of HAART to deplete persisting HIV-infected cell reservoirs Identification and frequency of CCR5Δ32/Δ32 HIV-resistant cord blood units from Houston area hospitals.Long-acting nanoformulated antiretroviral therapy elicits potent antiretroviral and neuroprotective responses in HIV-1-infected humanized mice.Impact of highly active antiretroviral therapy initiation on CD4(+) T-cell repopulation in duodenal and rectal mucosa.Viral decay kinetics in the highly active antiretroviral therapy-treated rhesus macaque model of AIDS.HIV Infection and Gut Mucosal Immune Function: Updates on Pathogenesis with Implications for Management and Intervention.Utilizing the FIV model to understand dendritic cell dysfunction and the potential role of dendritic cell immunization in HIV infection.Viral sanctuaries during highly active antiretroviral therapy in a nonhuman primate model for AIDS Mucosal T-cell responses to HIV: responding at the front lines Cycling of gut mucosal CD4+ T cells decreases after prolonged anti-retroviral therapy and is associated with plasma LPS levels.The complexity of HIV persistence and pathogenesis in the lung under antiretroviral therapy: challenges beyond AIDS.Modulation of gut-specific mechanisms by chronic δ(9)-tetrahydrocannabinol administration in male rhesus macaques infected with simian immunodeficiency virus: a systems biology analysis.HIV persistence: chemokines and their signalling pathways.Glycosylation, hypogammaglobulinemia, and resistance to viral infections

P2860

Q21135536-491AA6EC-8BDB-4E66-9D3D-93FBF8F04984 Q24654458-487541A9-E3E3-43C4-AB93-35DC3B0980CC Q26766705-E0C35F3F-D722-4583-8F21-BA7E81C27D6F Q26768632-E5987F69-064D-47FF-9283-9BB80B488BDB Q26781191-AFA59977-8924-48CC-884A-929D61DCD41F Q26827255-D92DAF1D-2809-462B-BCD9-094A23DDA789 Q26853069-025ECB4F-8EC1-48DA-AD2D-C8F1DFCF04F6 Q26864144-4E85A00C-7865-4B96-957C-D2AD491E8E4F Q27002959-FE67423B-3E47-43D6-8DD0-A018B342ACBD Q27013114-B9A1B8AE-DBB9-4C15-AC04-A32AAD536AC5 Q27021524-AFF007E5-365D-4506-9E69-04690A3B870B Q27322602-D84AB1CA-D67F-4438-B90D-3E96830EBBDD Q27329088-211CE8A9-80F9-4ED8-AFDA-E138B81440F8 Q27335485-53710AE0-92AC-4196-9884-6EBCEC8B7001 Q27347804-FDC61439-74DB-4393-A4F5-97BA5BEEE532 Q28067520-4391783E-D864-4CEB-8941-C1389FD93E1B Q28077662-3CB8A139-C47A-4C3F-9977-874CCE74E2D0 Q28478934-E76F7FAB-9385-4775-B462-1DF5D6B2FCE7 Q28552729-82E5BA5A-0B43-48FB-AD24-76EAC2674E72 Q28731610-EB66E37B-5C74-4370-9AD1-F88AE5D370A7 Q28741704-1AD0821D-7980-4C4F-A062-9377215EC8AD Q30245373-51C398F9-B5D0-4CAB-9D74-FF7BE2A80CB0 Q32183747-FA15704A-5B7C-4C78-B1F3-1FE840FEC926 Q33517859-F9745103-2F96-4D28-A63F-3B6E0D029D22 Q33523201-799C7A28-0A38-4B8C-8C61-1FDE1288FC65 Q33598231-EABADD94-8E4C-41EC-A165-488DF6A61C2E Q33604776-346FFAC3-6944-46FC-A95B-562D597BA26E Q33615123-D9003EDA-EBB7-4449-BC7B-BC4341F9BC9E Q33625213-8C1C6F98-CEA0-44FB-816E-88AA6E6A6D14 Q33631238-7F4A2573-DD7C-4BC5-B648-EC9926A98E31 Q33644248-7282F766-CE75-46C7-878C-DDD6D2FBC489 Q33651723-8154C91A-6095-48C1-A19A-0AABBB04CA46 Q33653728-F2962C17-1426-4E57-B360-E31EF94AC598 Q33676630-F35EA978-1AE9-40BD-A90A-FB7CF464A2E5 Q33681946-CCC1B7D9-9BF5-45CC-8BA1-0E72C221A399 Q33697836-BF40627E-EA2D-48D3-BFA2-195924BA3F23 Q33705883-C998F1EA-76C9-42BB-9637-FEA004ADC5E0 Q33713868-0C256EE5-ACC5-4B63-9DE0-C0442DEA92C6 Q33774665-3FC7E9C3-8136-4193-90F5-AA672830286A Q33789632-EEF0E56A-14FA-470D-B5AE-5BD6268BBE8E

P2860

Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy.

http://www.wikidata.org/entity/Q34588169

description

2008 nî lūn-bûn

@nan

2008 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի մարտին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Persistence of HIV in gut-asso ...... g-term antiretroviral therapy.

@ast

Persistence of HIV in gut-asso ...... g-term antiretroviral therapy.

@en

Persistence of HIV in gut-asso ...... g-term antiretroviral therapy.

@nl

type

label

Persistence of HIV in gut-asso ...... g-term antiretroviral therapy.

@ast

Persistence of HIV in gut-asso ...... g-term antiretroviral therapy.

@en

Persistence of HIV in gut-asso ...... g-term antiretroviral therapy.

@nl

prefLabel

Persistence of HIV in gut-asso ...... g-term antiretroviral therapy.

@ast

Persistence of HIV in gut-asso ...... g-term antiretroviral therapy.

@en

Persistence of HIV in gut-asso ...... g-term antiretroviral therapy.

@nl

P1433

Q34588169-8B438A2E-7AE7-4CFD-8466-E0E920668F74

P1476

Q34588169-BF3A8673-49D3-4FD4-8375-F642F9E895F5

P2093

Q34588169-06DE36D1-E8D2-43DF-BAF2-2D493E1780D7

Q34588169-15B58704-08CA-492D-A158-7A041DC5E6B3

Q34588169-4EF86645-19A8-4F11-B594-275FE92DC463

Q34588169-5EED5048-17F4-449A-9649-20D007FE406F

Q34588169-8345A1BC-6A36-4C98-99D5-F9D8E0B2FE03

Q34588169-9D17D3EF-404A-4CD6-945A-B1AB91FDB063

Q34588169-B7BBD9A5-1FC0-4975-B74A-B684D91F207F

Q34588169-CC87D87D-CDAD-4447-9980-5A0A6AA22FEF

Q34588169-DE65F5D0-4CAB-464E-B0D6-71CA3C1E3E2B

P2860

Q34588169-04A70EE3-E5E1-4BE5-BD5F-3414943D805A

Q34588169-3214DE87-CC49-4CF0-A83F-54B1036FCFE5

Q34588169-3DCCD361-E855-484B-9408-1875C88EA564

Q34588169-43342B18-C4E3-4617-B765-054FCBE9710E

Q34588169-48C4C802-FC07-4BE7-B710-8846283100AA

Q34588169-50C1AA62-2099-47D0-91F9-8C4974721182

Q34588169-5A999522-0E06-4325-A5C8-81DB18A23F99

Q34588169-61B67149-799E-42CD-BD10-D6E004039525

Q34588169-79B61DF6-C58B-4142-A939-B86E55621527

Q34588169-93C672C1-C588-4353-BCDF-D037065156D7

P304

Q34588169-37B7CB75-B0FE-4730-9E37-B8706DCEF624

P31

Q34588169-FCB5E007-4271-4327-9EAE-96EB6053510D

P356

Q34588169-0646F2B7-31A1-4B87-9D06-F0B2994E582C

P407

Q34588169-5713362F-7532-4FF8-9024-A277AF7B9FFE

P433

Q34588169-2C49E66F-DA84-435A-8B8C-5F37EC7631BD

P478

Q34588169-85FED98D-E2F8-4652-A20F-37B718A84E81

P50

Q34588169-2BBBBC95-CDA8-4C15-8669-3C616DE2A937

Q34588169-5E945CF7-D95E-429E-BA51-3C573076B3FE

Q34588169-6342B2F9-32A7-491E-B1FD-C90C6F7C619E

Q34588169-67F3EF2B-D477-4B72-A1FB-6C7F39653B10

Q34588169-AF43D6E6-E3D4-4485-8BA7-C62D2FE5CE1D

P577

Q34588169-0164F0D2-A04B-4A4F-8546-F82C02C800D4

P5875

Q34588169-018847FB-7E92-4027-8C9C-FF69B9D732B2

P698

Q34588169-4F2AA7E9-3EBD-4431-A9A2-68053533763E

P921

Q34588169-C21C47CF-28EC-4C34-A7EA-834BD1223A48

P356

P1433

The Journal of Infectious Diseases

P1476

Persistence of HIV in gut-asso ...... g-term antiretroviral therapy.

@en

P2093

David C Nickle

http://www.w3.org/2001/XMLSchema#string

Douglas J Ward

http://www.w3.org/2001/XMLSchema#string

Gregg Roby

http://www.w3.org/2001/XMLSchema#string

James I Mullins

http://www.w3.org/2001/XMLSchema#string

Jennifer H Meyers

http://www.w3.org/2001/XMLSchema#string

Jesse S Justement

http://www.w3.org/2001/XMLSchema#string

Joann M Mican

http://www.w3.org/2001/XMLSchema#string

Joseph A Kovacs

http://www.w3.org/2001/XMLSchema#string

Peter J Mannon

http://www.w3.org/2001/XMLSchema#string

P2860

MUSCLE: a multiple sequence alignment method with reduced time and space complexity

CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract

Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract

A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy

Recovery of replication-competent HIV despite prolonged suppression of plasma viremia

Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection

Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection

HIV-infected individuals receiving effective antiviral therapy for extended periods of time continually replenish their viral reservoir.

P304

714-720

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/527324

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

197

http://www.w3.org/2001/XMLSchema#string

P50

Claire W Hallahan

P577

2008-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5590981

http://www.w3.org/2001/XMLSchema#string

P698

18260759

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug